US PRECISION Implementation Study

Trial Identifier: D2287L00028
Sponsor: AstraZeneca
NCTID:: NCT04891978
Start Date: April 2021
Primary Completion Date: March 2023
Study Completion Date: March 2023
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
US, AL Birmingham, AL, US, 35209
US, FL Leesburg, FL, US, 34748
US, HI Honolulu, HI, US, 96819
US, IN Fort Wayne, IN, US, 46802
US, MA Tewksbury, MA, US, 01876
US, MI Ann Arbor, MI, US, 48109
US, NC Asheville, NC, US, 28801
US, NY Cornwall, NY, US, 12518
US, NY Rochester, NY, US, 14607
US, PA Philadelphia, PA, US, 19148
US, TX San Antonio, TX, US, 78249
US, VA Vienna, VA, US, 22182
US, WV Charleston, WV, US, 25304